Some hospitals are reporting an uptick in respiratory syncytial virus hospitalizations in recent days, though national data — delayed by the federal shutdown — has yet to offer a clear picture.

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

WellSpan Pediatric Medicine Physicians across the Midstate are seeing flu cases this week. “The colder weather is here and so are many cases of flu,” said Dr. Stephen Flack, medical director of ...

As flu season ramps up and COVID and RSV cases continue to circulate, many people are unsure which vaccines to get — and when ...

Dr. Stephen Feagins, medical director for Hamilton County Public Health, shares tips for moms, babies and elderly people.

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

Nirsevimab was found to be 80% effective at preventing respiratory syncytial virus-associated intensive care unit admissions during the 2024-2025 RSV season, according to a Centers for Disease Control ...

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

This Is Us' star Mandy Moore tells USA TODAY how she protects her 1-year-old daughter, Lou, from RSV after her sons ...